Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 14;13(1):26.
doi: 10.1186/s13722-018-0126-0.

Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder

Affiliations

Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder

Sarah M Bagley et al. Addict Sci Clin Pract. .

Abstract

Background: Little is known about opioid overdose or naloxone access among pregnant women.

Objectives: The objectives of this study were to determine the prevalence of non-fatal overdose, risk factors for overdose, and naloxone access among third trimester women in treatment for opioid use disorder.

Methods: We collected baseline data from a case management parental-support intervention study. To explore the association of variables with past year overdose, we used Wilcoxon rank-sum test, Chi square or Fisher's exact tests.

Results: Among 99 participants, 14% (95% CI 7-21%) reported past year overdose and 67% (95% CI 57-76%) had received overdose education and a naloxone kit. Younger age was the only variable associated with past year overdose.

Conclusions: In this sample, past year non-fatal overdose was common, younger age was a risk factor, and most participants had received a naloxone kit. Further work is needed to understand whether younger age is a risk factor in the general population of pregnant women with opioid use disorder and to identify other potential risk factors for overdose in this population.

Keywords: Naloxone; Opioids; Overdose; Pregnancy.

PubMed Disclaimer

References

    1. Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s National Naloxone Programme for reducing opioid-related deaths: a before (2006–10) versus after (2011–13) comparison. Addiction. 2016;111(5):883–891. doi: 10.1111/add.13265. - DOI - PMC - PubMed
    1. Department of Health and Human Services. (2015). Opioid abuse in the U.S. and HHS actions to address opioid-drug related overdoses and deaths. - PubMed
    1. Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002. doi: 10.1097/AOG.0000000000000208. - DOI - PMC - PubMed
    1. Edvardsson K, Ivarsson A, Eurenius E, Garvare R, Nyström ME, Small R, Mogren I. Giving offspring a healthy start: parents’ experiences of health promotion and lifestyle change during pregnancy and early parenthood. BMC Public Health. 2011;11(1):936. doi: 10.1186/1471-2458-11-936. - DOI - PMC - PubMed
    1. Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. Morb Mortal Wkly Rep. 2018;67(31):845. doi: 10.15585/mmwr.mm6731a1. - DOI - PMC - PubMed

Publication types

MeSH terms